Olivier Elemento
Cornell University
H-index: 111
North America-United States
Top articles of Olivier Elemento
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The spatial landscape of early-stage lung adenocarcinoma | Cancer Research | Junbum Kim Hiranmayi Ravichandran Liron Yoffe Bhavneet Binder Timothy McGraw | 2024/3/22 |
Deep generative AI models analyzing circulating orphan non-coding RNAs enable accurate detection of early-stage non-small cell lung cancer | medRxiv | Mehran Karimzadeh Amir Momen-Roknabadi Taylor B Cavazos Yuqi Fang Nae-Chyun Chen | 2024 |
MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in … | International Journal of Molecular Sciences | Erdal Tasci Yajas Shah Sarisha Jagasia Ying Zhuge Jason Shephard | 2024/4/6 |
Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts | Kidney International | Yajas Shah Hua Yang Franco B Mueller Carol Li Shab E Gul Rahim | 2024/2/1 |
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets | Modern Pathology | Majd Al Assaad Olivier Michaud Alissa Semaan Michael Sigouros Marvel Tranquille | 2024/2/16 |
Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women | JAMA surgery | Lisa A Newman Yalei Chen Rachel Martini Sandra Demaria Silvia Formenti | 2024/3/6 |
Balanced-strand sequencing for highly efficient duplex variant calling in circulating tumor DNA | Cancer Research | Adam Widman Alexandre P Cheng Aaron Sossin Srinivas Rajagopalan Majd Al Assaad | 2024/3/22 |
P589: Diagnostic yield of digital gene panel from genome sequencing in common multifactorial endocrine and metabolic disorders | Genetics in Medicine Open | Volkan Okur Sowmya Thirumalai Srinivasa Amanda Halstrom John Falcone Atteeq Rehman | 2024/1/1 |
569 Investigating the Role of FOXA2 During the Transition to Neuroendocrine Prostate Cancer | Journal of Clinical and Translational Science | Richard Garner Nicholas Brady Kate Dunmore Richa Singh Alyssa Bagadion | 2024/4 |
The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review | Christina Vivelo Karlyne M Reilly Brigitte C Widemann Mary Frances Wedekind Corrie Painter | 2024/2/1 | |
A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer | Cell Reports Medicine | Nasser K Altorki Bhavneet Bhinder Alain C Borczuk Olivier Elemento Vivek Mittal | 2024/2/13 |
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation | Cancer discovery | Gian Marco Franceschini Orsetta Quaini Kei Mizuno Francesco Orlando Yari Ciani | 2024/3/1 |
Spatial Atlas of Human Anatomy (SAHA): A subcellular, multiscale spatial odyssey of immune and gastrointestinal tissues and tumors | Cancer Research | Jiwoon Park Roberto Gregorio Erika Hissong Sanjay Patel Brian Robinson | 2024/3/22 |
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis | medRxiv | Stephanie Guillet Tomi Lazarov Natasha Jordan Bertrand Boisson Maria Tello | 2024 |
Rs2363956, a coding variant of ANKLE1, drives triple-negative breast cancer disparity by altering DNA damage response | Cancer Research | Yanira Guerra Rachel Martini Olivier Elemento Melissa B Davis | 2024/3/22 |
Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibition | M Laura Martin Rachel Martini Sarah Ackermann Colin Tang Marvel Tranquille | 2024/1/31 | |
Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort | PLOS Computational Biology | Yajas Shah Scott Kulm Jones T Nauseef Zhengming Chen Olivier Elemento | 2024/4/10 |
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity | Nature | Zihou Deng Pierre-Louis Loyher Tomi Lazarov Li Li Zeyang Shen | 2024/2/7 |
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment | Cancer Letters | Florencia P Madorsky Rowdo Gu Xiao Galina F Khramtsova John Nguyen Rachel Martini | 2024/3/1 |
PAIRWISE: Deep learning-powered personalized medicine approach identifies actionable drug combinations in B cell lymphoma | Cancer Research | Chengqi Xu Jake Cohen-Setton Zhouyang Shen Marta Milo Ilkay US | 2024/3/22 |
Co-Authors
